(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -30.02%-11.69M | 0.64%-11.1M | -40.75%-12.41M | 11.96%-39.52M | -16.13%-10.55M | 30.46%-8.99M | -10.87%-11.17M | 31.16%-8.81M | -30.75%-44.88M | -44.92%-9.08M |
Net income from continuing operations | 48.07%-8.06M | -976.82%-11.08M | -28.20%-32.24M | -17.33%-55.98M | -242.78%-16.58M | -21.61%-15.52M | 109.00%1.26M | -56.47%-25.15M | -19.61%-47.71M | 54.48%-4.84M |
Operating gains losses | -2,188.18%-9.54M | 63.24%-6.37M | -144.37%-4.54M | 27.78%-7.73M | 89.04%-1.1M | 189.43%457K | -4,596.75%-17.33M | 5,232.81%10.24M | -952.80%-10.71M | -11,887.06%-10.02M |
Depreciation and amortization | -28.42%1.88M | 46.18%2.52M | 126.53%2.62M | 78.80%8.15M | 122.78%2.64M | 121.15%2.63M | 45.04%1.73M | 16.28%1.16M | 316.16%4.56M | 343.82%1.19M |
Unrealized gains and losses of investment securities | 280.00%225K | -73.33%100K | 166.67%450K | -116.18%-275K | -78.57%150K | -112.50%-125K | --375K | ---675K | --1.7M | --700K |
Remuneration paid in stock | 126.27%1.96M | 220.82%2.59M | 46.74%854K | -64.84%3.06M | -43.65%808K | -47.86%864K | -65.64%807K | -82.18%582K | 30.41%8.71M | 427.21%1.43M |
Other non cashItems | -89.58%292K | -73.90%718K | 663.07%21.37M | 580.18%11.19M | 79.15%2.84M | 13,242.86%2.8M | 13,000.00%2.75M | 13,900.00%2.8M | -20.07%1.65M | 1,436.89%1.58M |
Change In working capital | 1,924.42%1.57M | 156.52%429K | -141.14%-917K | 167.73%2.08M | -20.32%694K | 97.55%-86K | -197.43%-759K | 284.83%2.23M | 5.51%-3.07M | -76.00%871K |
-Change in receivables | 11.13%-415K | 384.62%1.01M | -174.22%-426K | 202.56%236K | 30.09%-79K | -235.76%-467K | 133.23%208K | 21.35%574K | 102.53%78K | 89.46%-113K |
-Change in prepaid assets | 282.33%1.69M | -345.61%-1.48M | -63.65%558K | 387.57%1.06M | -112.58%-146K | 76.92%-928K | -41.91%603K | 5.72%1.54M | 85.51%-370K | -37.14%1.16M |
-Change in payables and accrued expense | -66.59%418K | 163.02%1.04M | -1,077.89%-929K | 121.75%608K | 559.90%906K | 658.18%1.25M | -547.96%-1.64M | 103.03%95K | -171.67%-2.8M | -106.90%-197K |
-Change in other working capital | -317.24%-126K | -281.08%-134K | -580.00%-120K | 750.00%170K | --13K | --58K | --74K | --25K | 101.32%20K | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -30.02%-11.69M | 0.64%-11.1M | -40.75%-12.41M | 11.96%-39.52M | -16.13%-10.55M | 30.46%-8.99M | -10.87%-11.17M | 31.16%-8.81M | -30.75%-44.88M | -44.92%-9.08M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -136.15%-5.26M | 69.16%-1.56M | -56.00%-2.22M | 64.02%-10.07M | 88.04%-1.36M | 61.66%-2.23M | -3.29%-5.06M | 75.96%-1.43M | 19.03%-28M | 14.50%-11.36M |
Net PPE purchase and sale | -130.84%-5.39M | 67.78%-1.66M | -55.84%-2.31M | 45.99%-14.41M | 39.18%-5.43M | 60.66%-2.34M | 10.60%-5.16M | 75.48%-1.48M | 27.87%-26.68M | 38.95%-8.93M |
Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---2.5M | --0 |
Net other investing changes | 21.30%131K | 3.03%102K | 51.79%85K | 267.37%4.34M | 267.43%4.07M | -95.89%108K | -88.65%99K | -50.00%56K | -50.96%1.18M | -281.63%-2.43M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -136.15%-5.26M | 69.16%-1.56M | -56.00%-2.22M | 64.02%-10.07M | 88.04%-1.36M | 61.66%-2.23M | -3.29%-5.06M | 75.96%-1.43M | 19.03%-28M | 14.50%-11.36M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -71.22%-351K | -105.85%-1.61M | 7,684.82%66.44M | -62.61%26.29M | -100.34%-225K | -270.83%-205K | 760.37%27.59M | -2,046.67%-876K | -44.09%70.29M | 9,067.26%66.92M |
Net issuance payments of debt | -5.99%-177K | -312.73%-681K | -10.32%-171K | -101.07%-712K | -100.34%-225K | -8.44%-167K | -9.27%-165K | -13.14%-155K | 5,564.32%66.61M | 515,684.62%67.05M |
Net common stock issuance | --0 | --0 | --67.87M | 641.53%29.57M | --0 | --0 | 679.05%29.57M | --0 | -96.51%3.99M | --0 |
Proceeds from stock option exercised by employees | --59K | ---- | ---- | -21.74%576K | --0 | --0 | ---- | ---- | -96.29%736K | -92.76%67K |
Net other financing activities | -513.16%-233K | 49.83%-1.2M | -74.20%-1.26M | -202.21%-3.14M | --0 | 2.56%-38K | -346.44%-2.38M | -168.03%-721K | 85.40%-1.04M | 4.81%-198K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -71.22%-351K | -105.85%-1.61M | 7,684.82%66.44M | -62.61%26.29M | -100.34%-225K | -270.83%-205K | 760.37%27.59M | -2,046.67%-876K | -44.09%70.29M | 9,067.26%66.92M |
Net cash flow | ||||||||||
Beginning cash position | 23.44%73.88M | 80.40%88.03M | -39.37%36.33M | -3.90%59.92M | 246.25%48.59M | 86.38%59.85M | 12.21%48.8M | -3.90%59.92M | 1,279.54%62.36M | -82.74%14.03M |
Current changes in cash | -51.46%-17.3M | -225.57%-14.27M | 566.16%51.81M | -801.08%-23.3M | -126.10%-12.13M | 38.64%-11.42M | 196.57%11.36M | 40.52%-11.12M | -104.55%-2.59M | 346.91%46.48M |
Effect of exchange rate changes | -148.17%-79K | 135.78%112K | -927.27%-113K | -287.10%-290K | 77.89%-130K | -69.35%164K | -180.46%-313K | 93.92%-11K | -84.61%155K | -434.55%-588K |
End cash Position | 16.28%56.5M | 23.44%73.88M | 80.40%88.03M | -39.37%36.33M | -39.37%36.33M | 246.25%48.59M | 86.38%59.85M | 12.21%48.8M | -3.90%59.92M | -3.90%59.92M |
Free cash from | -50.81%-17.08M | 21.86%-12.76M | -42.92%-14.71M | 24.65%-53.92M | 11.29%-15.98M | 39.97%-11.32M | -3.05%-16.33M | 45.37%-10.3M | -0.35%-71.56M | 13.79%-18.01M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data